Kamu erişimi zorunlu olan makaleler - Guruprasad AithalDaha fazla bilgi edinin
Hiçbir yerde sunulmuyor: 8
HLA-DRB1* 16: 01-DQB1* 05: 02 is a novel genetic risk factor for flupirtine-induced liver injury
P Nicoletti, AN Werk, A Sawle, Y Shen, TJ Urban, SA Coulthard, ...
Pharmacogenetics and genomics 26 (5), 218-224, 2016
Zorunlu olanlar: UK Medical Research Council, National Institute for Health Research, UK …
Human leukocyte antigen genetic risk factors of drug-induced liver toxicology
JI Grove, GP Aithal
Expert opinion on drug metabolism & toxicology 11 (3), 395-409, 2015
Zorunlu olanlar: National Institute for Health Research, UK
Diagnosis, presentation and initial severity of autoimmune hepatitis (AIH) in patients attending 28 hospitals in the UK
V Gordon, R Adhikary, V Appleby, D Das, J Day, T Delahooke, S Dixon, ...
Liver International 38 (9), 1686-1695, 2018
Zorunlu olanlar: UK Medical Research Council
Genome-wide association studies in drug-induced liver injury: step change in understanding the pathogenesis
GP Aithal, JI Grove
Seminars in liver disease 35 (04), 421-431, 2015
Zorunlu olanlar: National Institute for Health Research, UK
Community-based assessment and treatment of hepatitis C virus-related liver disease, injecting drug and alcohol use amongst people who are homeless: a systematic review and …
A Hashim, L Macken, AM Jones, M McGeer, GP Aithal, S Verma
International Journal of Drug Policy 96, 103342, 2021
Zorunlu olanlar: Dunhill Medical Trust, UK, National Institute for Health Research, UK
Incidence of post-ERCP pancreatitis from direct pancreatic juice collection in hereditary pancreatitis and familial pancreatic cancer before and after the introduction of …
JA Nicholson, W Greenhalf, R Jackson, TF Cox, JV Butler, T Hanna, ...
Pancreas 44 (2), 260-265, 2015
Zorunlu olanlar: Cancer Research UK, National Institute for Health Research, UK, Pancreatic …
Current and future magnetic resonance technologies for assessing liver disease in clinical and experimental medicine
SJ Bawden, RA Scott, GP Aithal
Digestive Diseases 35 (4), 314-322, 2017
Zorunlu olanlar: National Institute for Health Research, UK
Glycated haemoglobin is a major predictor of disease severity in patients with NAFLD
S Colosimo, H Miller, DA Koutoukidis, T Marjot, GD Tan, DJ Harman, ...
Diabetes research and clinical practice 217, 111820, 2024
Zorunlu olanlar: UK Medical Research Council, National Institute for Health Research, UK …
Bir yerde sunuluyor: 204
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
MJ Armstrong, P Gaunt, GP Aithal, D Barton, D Hull, R Parker, ...
The Lancet 387 (10019), 679-690, 2016
Zorunlu olanlar: UK Medical Research Council, National Institute for Health Research, UK …
Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
SA Ratziu V, Harrison SA, Francque S, Bedossa P, Lehert P, Serfaty L, Romero ...
Gastroenterology 150 (5), 1147-1159, 2016
Zorunlu olanlar: US National Institutes of Health
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ...
The Lancet 394 (10215), 2184-2196, 2019
Zorunlu olanlar: National Institute for Health Research, UK
A randomized, placebo‐controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
SL Friedman, V Ratziu, SA Harrison, MF Abdelmalek, GP Aithal, ...
Hepatology 67 (5), 1754-1767, 2018
Zorunlu olanlar: US National Institutes of Health, UK Medical Research Council
TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease
YL Liu, HL Reeves, AD Burt, D Tiniakos, S McPherson, JBS Leathart, ...
Nature communications 5 (1), 4309, 2014
Zorunlu olanlar: National Institute for Health Research, UK
EASL clinical practice guidelines: drug-induced liver injury
RJ Andrade, GP Aithal, ES Björnsson, N Kaplowitz, GA Kullak-Ublick, ...
Journal of hepatology 70 (6), 1222-1261, 2019
Zorunlu olanlar: European Commission
Drug-induced liver injury
RJ Andrade, N Chalasani, ES Björnsson, A Suzuki, GA Kullak-Ublick, ...
Nature Reviews Disease Primers 5 (1), 58, 2019
Zorunlu olanlar: European Commission
Incidence and etiology of drug-induced liver injury in mainland China
T Shen, Y Liu, J Shang, Q Xie, J Li, M Yan, J Xu, J Niu, J Liu, PB Watkins, ...
Gastroenterology 156 (8), 2230-2241. e11, 2019
Zorunlu olanlar: National Natural Science Foundation of China, UK Medical Research Council
Drug-induced liver injury: recent advances in diagnosis and risk assessment
GA Kullak-Ublick, RJ Andrade, M Merz, P End, A Benesic, AL Gerbes, ...
Gut 66 (6), 1154-1164, 2017
Zorunlu olanlar: Swiss National Science Foundation, UK Medical Research Council
Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles
MI Lucena, M Molokhia, Y Shen, TJ Urban, GP Aithal, RJ Andrade, ...
Gastroenterology 141 (1), 338-347, 2011
Zorunlu olanlar: US National Institutes of Health, Government of Spain
Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆
QM Anstee, R Darlay, S Cockell, M Meroni, O Govaere, D Tiniakos, ...
Journal of hepatology 73 (3), 505-515, 2020
Zorunlu olanlar: UK Medical Research Council, National Institute for Health Research, UK …
Indications, results, and clinical impact of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Clinical …
JM Dumonceau, PH Deprez, C Jenssen, J Iglesias-Garcia, A Larghi, ...
Endoscopy 49 (7), 695-714, 2017
Zorunlu olanlar: UK Medical Research Council
Yayıncılık ve maddi kaynak bilgileri otomatik olarak bir bilgisayar programı tarafından belirlenmektedir